The functions of this core facility are to provide an efficient, economical and effective use of animals for the performance of cancer- related studies. A significant emphasis is placed on the use of immune- deficient rodents. Major services provided by the Animal Core Facility include: coordination of animal purchase requests; inoculation of tumor cells into animals; in vivo propagation of tumor cell lines in animals; measurement of tumors; administration of carcinogens, drugs and hormonal agents; collection of tumors, organs, and sera. A service for the production of rabbit polyclonal antisera is also provided. Small transgenic and C3H OUJ mouse breeding colonies are maintained. Two additional rooms are also maintained to N.I.H. Biosafety Level 2 standards for investigators using retroviral vectors and chemical carcinogens. The facility is located within Georgetown University Medical School's Research Resources Facility (RRF). The RRF is a centralized, AAALAC accredited, USDA registered, animal facility and has an approved letter of assurance on file at the N.I.H. All cell lines for inoculation require evidence of current Murine Antibody Production test status. The general environment and animal health is monitored by the use of sentinel mice are maintained in each animal room. All immune-deficient rodents are maintained within a Specific Pathogen free environment. The services of this facility are critical to the effective and economical use of animals by Lombardi Cancer Center investigators. In FY 91-92, these services were used in support of 16 peer-reviewed projects in 7 Cancer Center Programs. At the time of the previous CCSG application, this facility had the capacity to maintain up to 600 athymic nude mice at any one time. Continuing increase in demand has required a 50% expansion in space required to maintain immune-deficient rodents. We anticipate a further 50% increase in usage over the next 5 year period. A substantial proportion of this increase will occur within the first 24 months.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA051008-04
Application #
3773523
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lee, Shiao-Pieng; Kao, Chen-Yu; Chang, Shun-Cheng et al. (2018) Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin. PLoS One 13:e0192632
Paffhausen, Emily S; Alowais, Yasir; Chao, Cara W et al. (2018) Discovery of a stem-like multipotent cell fate. Am J Stem Cells 7:25-37
Akinyemiju, Tomi F; Demb, Joshua; Izano, Monika A et al. (2018) The association of early life socioeconomic position on breast cancer incidence and mortality: a systematic review. Int J Public Health 63:787-797
Tiek, D M; Rone, J D; Graham, G T et al. (2018) Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma. Sci Rep 8:7222
Furth, Priscilla A (2018) Peroxisome proliferator-activated receptor gamma and BRCA1. Endocr Relat Cancer :
Sehrawat, Archana; Gao, Lina; Wang, Yuliang et al. (2018) LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A 115:E4179-E4188
Gusev, Yuriy; Bhuvaneshwar, Krithika; Song, Lei et al. (2018) The REMBRANDT study, a large collection of genomic data from brain cancer patients. Sci Data 5:180158
Oppong, Bridget A; Dash, Chiranjeev; O'Neill, Suzanne et al. (2018) Breast density in multiethnic women presenting for screening mammography. Breast J 24:334-338
Fernandez, Harvey R; Gadre, Shreyas M; Tan, Mingjun et al. (2018) The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer. Cell Death Differ 25:1239-1258
Schmidt, Marcel Oliver; Garman, Khalid Ammar; Lee, Yong Gu et al. (2018) The Role of Fibroblast Growth Factor-Binding Protein 1 in Skin Carcinogenesis and Inflammation. J Invest Dermatol 138:179-188

Showing the most recent 10 out of 1120 publications